CP and hepatocellular carcinoma: Experimental validation further demonstrated that CP administration might promote autophagic degradation of Cav-1, therefore triggering ubiquitination and proteasome-associated degradation of β-catenin, and suppressing progression and metastasis of HBV-associated HCC in vitro and in vivo.